SUVRETTA CAPITAL MANAGEMENT, LLC

Position in LEGN — Legend Biotech Corp

CIK 1569064 New York, NY

Position in LEGN

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$137,140,814

-$6,530,780 QoQ

Shares Held

7,581,029

+14.7% QoQ

Ownership

2.05%

of shares outstanding

% of Portfolio

3.75%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. LEGN ranks #5 (5.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc.	12,327,000	$290,424,120
2	MANE	Veradermics, Inc	4,168,970	$263,270,455
3	PVLA	Palvella Therapeutics, Inc.	1,153,496	$143,783,276
4	APLS	Apellis Pharmaceuticals, Inc.	3,518,471	$141,548,088
5	LEGN	Legend Biotech Corp This page	7,581,029	$137,140,814
6	BNTC	Benitec Biopharma Inc.	11,548,351	$122,989,938
7	CAPR	Capricor Therapeutics, Inc.	3,818,600	$116,085,440
8	IMTX	Immatics N.V.	11,190,129	$110,110,869

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$137,140,814	7,581,029	+14.7%	Shares	Sole	2026-05-15
2025-12-31	$143,671,594	6,608,629	+73.1%	Shares	Sole	2026-02-17
2025-09-30	$124,505,273	3,818,009	+1.2%	Shares	Sole	2025-11-14
2025-06-30	$133,939,579	3,774,009	+0.6%	Shares	Sole	2025-08-14
2025-03-31	$127,236,312	3,749,965	+7.3%	Shares	Sole	2025-05-15
2024-12-31	$113,767,454	3,496,234	+1175.1%	Shares	Sole	2025-02-14
2022-09-30	$11,187,360	274,200	+174.2%	Shares	Sole	2022-11-14
2020-06-30	$4,256,000	100,000	—	Shares	Sole	2020-08-14
No filing history on record for this holder in this stock.